|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Fixed income securities, at fair value (net of allowance for expected credit losses of $0 at June 30, 2023 and $0 at December 31, 2022) | ||||||||||||||||||||
| Fixed income securities, at fair value (amortized cost $314,055 and $314,804; net of allowance for expected credit losses of $0 and $0) | ||||||||||||||||||||
| Equity securities, at fair value (cost $19,753 and $20,926) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total cash and investments | ||||||||||||||||||||
| Premiums and agents' balances receivable (net of allowance for expected credit losses of $434 at June 30, 2023 and $425 at December 31, 2022) | ||||||||||||||||||||
| Premiums and agents' balances receivable (net of allowance for expected credit losses of $301 and $334) | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Reinsurance premiums receivable | ||||||||||||||||||||
| Reinsurance recoverables on losses (net of allowance for expected credit losses of $0 and $0) | ||||||||||||||||||||
| Income tax recoverable | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Receivable from Federal Crop Insurance Corporation | ||||||||||||||||||||
| Goodwill and other intangibles | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Reinsurance premiums payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, $0.01 par value, authorized: 25,000,000 shares; issued: 23,000,000 shares; and outstanding: 2026 – 20,431,819 shares, 2025 – 20,554,144 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Unearned employee stock ownership plan shares | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of income taxes | ||||||||||||||||||||
| Treasury stock, at cost, 2026 – 2,547,016 shares, 2025 – 2,424,691 shares | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
